These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. Wu YH, Yu B, Chen WX, Ai X, Zhang W, Dong W, Shao YJ. Aging (Albany NY); 2021 Aug 02; 13(15):19260-19271. PubMed ID: 34341185 [Abstract] [Full Text] [Related]
3. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K. Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188 [Abstract] [Full Text] [Related]
4. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. Zhang YT, Li BP, Zhang B, Ma P, Wu QL, Ming L, Xie LM. Eur Rev Med Pharmacol Sci; 2018 Oct 19; 22(19):6333-6341. PubMed ID: 30338801 [Abstract] [Full Text] [Related]
5. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma. Tang YH, He GL, Huang SZ, Zhong KB, Liao H, Cai L, Gao Y, Peng ZW, Fu SJ. Mol Oncol; 2019 May 19; 13(5):1296-1310. PubMed ID: 30943320 [Abstract] [Full Text] [Related]
6. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu R, Chen T, Niu Y, Tu K, Liu Q. J Exp Clin Cancer Res; 2019 May 14; 38(1):194. PubMed ID: 31088485 [Abstract] [Full Text] [Related]
8. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p. Deng Y, Wei Z, Huang M, Xu G, Wei W, Peng B, Nong S, Qin H. J Cell Mol Med; 2020 Jan 14; 24(2):1848-1865. PubMed ID: 31880390 [Abstract] [Full Text] [Related]
9. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma. Wang YD, Sun XJ, Yin JJ, Yin M, Wang W, Nie ZQ, Xu J. Biomed Pharmacother; 2018 Oct 14; 106():134-141. PubMed ID: 29957463 [Abstract] [Full Text] [Related]
10. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway. Liu J, Liu R, Liu Y, Li L, Cao H, Liu J, Cao G. Cell Cycle; 2021 Jun 14; 20(12):1134-1146. PubMed ID: 34097562 [Abstract] [Full Text] [Related]
11. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression. Zhang X, Xu S, Hu C, Fang K, Zhou J, Guo Z, Zhu G, Li L. Biochem Biophys Res Commun; 2020 Dec 17; 533(4):1039-1047. PubMed ID: 33012505 [Abstract] [Full Text] [Related]
12. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. He H, Wang Y, Ye P, Yi D, Cheng Y, Tang H, Zhu Z, Wang X, Jin S. J Exp Clin Cancer Res; 2020 Aug 14; 39(1):159. PubMed ID: 32795316 [Abstract] [Full Text] [Related]
13. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J, Dai C, Yu X, Yin XB, Zhou F. J Cell Biochem; 2021 Jan 14; 122(1):86-99. PubMed ID: 32786108 [Abstract] [Full Text] [Related]
14. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression. Zhu H, Zhang H, Pei Y, Liao Z, Liu F, Su C, Liu Y, Dong R, Song J, Zhang X, Fan Y, Liang H, Zhang B, Chen X. J Exp Clin Cancer Res; 2021 Feb 04; 40(1):57. PubMed ID: 33541391 [Abstract] [Full Text] [Related]
15. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A. Zhou C, Chen Z, Peng C, Chen C, Li H. Cancer Biother Radiopharm; 2021 Mar 04; 36(2):211-219. PubMed ID: 32391716 [Abstract] [Full Text] [Related]
16. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1. Dong H, Jian P, Yu M, Wang L. J Cell Physiol; 2020 Oct 04; 235(10):6548-6562. PubMed ID: 32068261 [Abstract] [Full Text] [Related]
17. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway. Yang J, Li C, Li H, E C. J Cell Physiol; 2019 Aug 04; 234(10):18415-18422. PubMed ID: 30908634 [Abstract] [Full Text] [Related]
18. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis. Zhu X, Jiang S, Wu Z, Liu T, Zhang W, Wu L, Xu L, Shao M. Bioengineered; 2021 Dec 04; 12(1):578-588. PubMed ID: 33517826 [Abstract] [Full Text] [Related]
19. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K. Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020 [Abstract] [Full Text] [Related]
20. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma. Chen J, Wu D, Zhang Y, Yang Y, Duan Y, An Y. Clin Sci (Lond); 2019 Jan 31; 133(2):367-379. PubMed ID: 30617187 [Abstract] [Full Text] [Related] Page: [Next] [New Search]